TT
Tango Therapeutics, Inc.
SEC filingPharmaceuticals · Boston, MA
Amount raised$15Msold at filing
Total offering$15M
Investors in the raise1count reported to the SEC
FiledOct 28, 2025first sale Oct 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
John Ann KetchumDirector
Barbara WeberExecutive Officer, Director
Malte Ann PetersDirector
Kanishka Ann PothulaDirector
Lesley Ann CalhounDirector
Mace Ann RothenbergDirector
Alexis BorisyDirector
Adam CrystalExecutive Officer
Daniella BeckmanExecutive Officer
Executive officers, directors and promoters as listed on the Form D.